| Safety of COVID-19 vaccines in multiple sclerosis: A systematic review and meta-analysis MI Stefanou, L Palaiodimou, A Theodorou, MV Christodoulou, JS Tzartos, ... Multiple Sclerosis Journal 29 (4-5), 585-594, 2023 | 21 | 2023 |
| Recurrent fulminant tumefactive demyelination with marburg-like features and atypical presentation: therapeutic dilemmas and review of literature AG Vakrakou, D Tzanetakos, T Argyrakos, G Koutsis, ME Evangelopoulos, ... Frontiers in neurology 11, 536, 2020 | 19 | 2020 |
| Hippocampal structural and functional integrity in multiple sclerosis patients with or without memory impairment: a multimodal neuroimaging study E Karavasilis, F Christidi, G Velonakis, D Tzanetakos, I Zalonis, C Potagas, ... Brain imaging and behavior 13, 1049-1059, 2019 | 17 | 2019 |
| Heterogeneity of Baló’s concentric sclerosis: a study of eight cases with different therapeutic concepts D Tzanetakos, AG Vakrakou, JS Tzartos, G Velonakis, ... BMC neurology 20, 1-10, 2020 | 15 | 2020 |
| Deciphering anti-MOG IgG antibodies: clinical and radiological spectrum, and comparison of antibody detection assays JS Tzartos, K Karagiorgou, D Tzanetakos, M Breza, ME Evangelopoulos, ... Journal of the Neurological Sciences 410, 116673, 2020 | 15 | 2020 |
| Novel cell-based assay for alpha-3 nicotinic receptor antibodies detects antibodies exclusively in autoimmune autonomic ganglionopathy K Karagiorgou, M Dandoulaki, R Mantegazza, F Andreetta, R Furlan, ... Neurology: Neuroimmunology & Neuroinflammation 9 (3), e1162, 2022 | 14 | 2022 |
| Clinico-radiologic features and therapeutic strategies in tumefactive demyelination: a retrospective analysis of 50 consecutive cases AG Vakrakou, D Tzanetakos, ME Evangelopoulos, T Argyrakos, ... Therapeutic Advances in Neurological Disorders 14, 17562864211006503, 2021 | 14 | 2021 |
| Recurrent myelitis and asymptomatic hypophysitis in IgG4-related disease: case-based review AG Vakrakou, ME Evangelopoulos, G Boutzios, D Tzanetakos, J Tzartos, ... Rheumatology International 40 (2), 337-343, 2020 | 14 | 2020 |
| MOG antibody-associated demyelinating disease mimicking typical multiple sclerosis: a case for expanding anti-MOG testing? M Breza, G Koutsis, JS Tzartos, G Velonakis, ME Evangelopoulos, ... Multiple Sclerosis and Related Disorders 33, 67-69, 2019 | 11 | 2019 |
| X linked Charcot-Marie-Tooth disease and multiple sclerosis: emerging evidence for an association G Koutsis, M Breza, G Velonakis, J Tzartos, D Kasselimis, C Kartanou, ... Journal of Neurology, Neurosurgery & Psychiatry 90 (2), 187-194, 2019 | 10 | 2019 |
| A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes AG Vakrakou, D Tzanetakos, S Valsami, E Grigoriou, K Psarra, J Tzartos, ... BMC neurology 18, 1-6, 2018 | 9 | 2018 |
| Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease AG Vakrakou, E Karachaliou, E Chroni, V Zouvelou, D Tzanetakos, ... Frontiers in Immunology 14, 1212757, 2023 | 8 | 2023 |
| Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion JS Tzartos, S Valsami, D Tzanetakos, C Stergiou, M Dandoulaki, ... Neurology: Neuroimmunology & Neuroinflammation 7 (3), e711, 2020 | 8 | 2020 |
| Cerebral Amyloid Angiopathy—Related Inflammation: A Single-Center Experience and a Literature Review A Theodorou, L Palaiodimou, A Safouris, O Kargiotis, K Psychogios, ... Journal of Clinical Medicine 11 (22), 6731, 2022 | 7 | 2022 |
| Cortical involvement and Leptomeningeal inflammation in myelin Oligodendrocyte glycoprotein antibody disease: A three-dimensional fluid-attenuated inversion recovery MRI study D Tzanetakos, JS Tzartos, AG Vakrakou, M Breza, G Velonakis, ... Multiple Sclerosis Journal 28 (5), 718-729, 2022 | 6 | 2022 |
| Thyroid autoimmunity following alemtuzumab treatment in multiple sclerosis patients: a prospective study P Kazakou, D Tzanetakos, AG Vakrakou, JS Tzartos, ΜE Evangelopoulos, ... Clinical and Experimental Medicine 23 (6), 2885-2894, 2023 | 4 | 2023 |
| Real-world assessment of quality of life in patients with relapsing remitting multiple sclerosis treated with teriflunomide for two years: patient-reported outcomes from the … E Dardiotis, G Perpati, M Borsos, I Nikolaidis, D Tzanetakos, G Deretzi, ... Neurology and Therapy 11 (3), 1375-1390, 2022 | 4 | 2022 |
| IgG4-related autoimmune manifestations in Alemtuzumab-treated multiple sclerosis patients AG Vakrakou, D Tzanetakos, ME Evangelopoulos, GE Fragoulis, ... Journal of Neuroimmunology 361, 577759, 2021 | 4 | 2021 |
| Chronic inflammatory demyelinating polyneuropathy associated with Rickettsia conorii: First case report D Tzanetakos, M Papadopoulou, D Kanellopoulos, M Mamali, ... Journal of the Neurological Sciences 371, 60-61, 2016 | 4 | 2016 |
| HLA-genotyping by next-generation-sequencing reveals shared and unique HLA alleles in two patients with coexisting neuromyelitis optica spectrum disorder and thymectomized … A Vakrakou, T Chatzistamatiou, C Koros, D Karathanasis, ... Multiple Sclerosis and Related Disorders 63, 103858, 2022 | 3 | 2022 |
